FDA Inspection
Medpace IncMedpace Inc – FDA Inspection, Apr 20, 2018
Record Details
This FDA Inspection record concerns Medpace Inc, with an inspection on April 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4de49c82-defe-41d5-b071-c87d004f46e4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050553
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.56(b)Investigator non-compliance
- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medpace Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Cincinnati District Office | |
| February 13, 2025 | Not classified | Cincinnati District Office | |
| July 11, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 26, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Medpace Inc
- FDA Inspection 1332930 - 2026-07-31
- FDA Inspection 1263213 - 2025-02-13
- FDA Inspection 1245618 - 2024-07-11
- FDA Inspection 1232744 - 2024-03-06
- FDA Inspection 1169068 - 2022-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.